For the first time in almost 20 years the FDA has approved a new Alzheimer’s and dementia treatment. Aduhelm (aducanamab) treats the actual underlying biology of Alzheimer’s disease, not just the symptoms. As a monthly infusion treatment, Adulhelm slows the progression of Mild Cognitive Impairment (MCI) due to Alzheimer’s disease or Alzheimer’s dementia in its earliest stage. The approval of this treatment gives hope to diagnosed individuals and their loved ones.
Infusion for Health is proud to be one of the first treatment providers in Southern California.
Phone: (805) 719-3700
FAX: (805) 852-2636
Contact us today using the number above, or complete the form below, to learn more about treatment options. Referring providers can also download the new ADUHELM order set here: Order Sets.